Arbutus Biopharma Corporation
(NASDAQ : TKMR)

( )
TKMR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.27%93.671.3%$1008.13m
BIIBBiogen Inc.
-0.53%229.001.3%$683.49m
AMGNAmgen Inc.
0.41%180.491.3%$471.95m
GILDGilead Sciences, Inc.
0.10%63.100.9%$441.95m
ILMNIllumina, Inc.
0.26%322.883.5%$285.89m
REGNRegeneron Pharmaceuticals, Inc.
0.83%347.002.6%$277.64m
VRTXVertex Pharmaceuticals Incorporated
4.07%175.371.9%$247.10m
ALXNAlexion Pharmaceuticals, Inc.
-0.28%132.002.0%$174.70m
EXASExact Sciences Corporation
3.61%93.9425.3%$160.74m
SRPTSarepta Therapeutics, Inc.
0.00%118.0914.7%$144.55m
AAgilent Technologies, Inc.
-0.04%75.541.6%$142.04m
ONCESpark Therapeutics, Inc.
0.00%110.6011.2%$133.55m
INCYIncyte Corporation
2.38%75.412.5%$98.69m
IONSIonis Pharmaceuticals, Inc.
0.00%75.008.3%$95.31m
BMRNBioMarin Pharmaceutical Inc.
0.00%86.004.3%$93.68m

Company Profile

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.